Lupus Suspection Expert System Using Artificial Neural Networks (ANN)
DOI:
https://doi.org/10.26438/ijcse/v9i11.1923Keywords:
VSLE, Hematocrit, WBC, , SLTAbstract
Lupus, often detected as a chronic disease, is beyond any measure of cure. ANN (Artificial Neural Network) is used to suspect lupus disease in this research paper. If treated in an early stage, this disease can be controlled. Early diagnosis of lupus is required to treat it properly. It is very difficult to diagnose lupus manually by observing various symptoms. An approach is given to diagnose lupus in an efficient way with the help of ANN. An ANN has been designed here to suspect lupus based on laboratory test reports. Lupus is a chronic disease. The ANN consists of many neurons associated with weights. Each test report is dependent on the existence of each neuron. The present paper aimed at designing an Artificial Neural Network model to diagnose the stage of Lupus. Here the data has been collected from North Bengal Medical College for training the network. The proposed ANN used here is a supervised type, where different patterns represent different status of patient.
References
[1] Farhad Soleimanian Gharehchopogh, Maryam Molany and Freshte DabaghchiMokri, “Using Artificial Neural Network in diagnosis of thyroid disease”: a case Study, International Journal Computational Sciences & Applications (IJCSA) Vol.3, No.4, August 2013
[2] R. Dey, V. Bajpai, G. Gandhi, B. Dey, “Application of Artificial Neural Network (ANN) technique for Diagnosing Diabetes Mellitus”, the Third international Conference on Industrial and Information Systems(ICIIS), IEEE, Kharagpur, India, PP.1-4, 2008.
[3] F.S. Gharehchopogh, Z.A. Khalifelu,” Neural Network Application in Diagnosis of Patient: A Case Study”, International Conference on Computer Networks and Information Technology (ICCNIT), PP- 245 – 249, Abbottabad, Pakistan, 2011.Study”, International Conference on Computer Networks and Information Technology (ICCNIT), Abbottabad, Pakistan, PP. 245 – 249, 2011.
[4] Payel Saha, Rakesh Kumar Mondal “Detection Of Dengue Disease using Artificial neural Network” International Journal of Computer Sciences and Engineering , May 12, 2016.
[5] Matthew H. Liang, Steven A Socher, Martin G. Larson and Peter H. Schur “ Reliability and Validity of Six Systems for the Clinical Assessment of disease activity in systemic Lupus Erythematosus”, Artheritis Rheum. September,1989; 32(9):1107-18.
[6] Thomas Stoll, Gerold Stucki, Javid Malik, Stephen Pyke, David A Isenberg “ Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus”, 756-760, 1996
[7] E.M. Hay, P.A. Bacon, C. GorDon, D.A. Isenberg, P. Maddison, M.L. Snaith, D.P.M. Symmons, N. Viner and A. Zoma “The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupuserythematosus”, Quaterly Journal of Medicine, 1993; 86:447-458.
[8] Gary S.Firestein, Ralph Budd, Sherine E Gabriel, Iain B. Mclnnes, James R O’Dell “ Kelly and Firestein’s Textbook of Rheumatology”
[9] D.P.M. Symmons, J.S.Coppock, P.A. Bacon, B. Bresnihan, D.A. Isenberg, P.Maddison, N. Mchugh, M.L.Snaith and A.S.zoma “Development and Assessment of a Computerized Index of Clinical Disease Activity in Systemic Lupus Erythematosus”,Quarterly Journal of Medicine, New Series 69, No.258, PP.927-937, November 1988.
[10] Annegret Kuhn, Asyche Landmann “ The Classification and diagnosis of cutaneous lupus erythematosus”, Journal of Autoimmunity, 2014.
[11] Claire Bombardier, Dafna D. Gladman, Murray B. Urowitz, Dominique Caron, Chi Hsing Chang and the Committee on Prognosis Studies in SLE “ Derivation Of The SLEDAI A Disease Activity Index for /lupus Patients”, Arthritis and Rheumatism, Vol.35, No.6 June,1992.
[12] Laurene Fausett, “Fundamentals of Neural Networks”, Pearson publication, India PP. 59-62 , 1994.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors contributing to this journal agree to publish their articles under the Creative Commons Attribution 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit and that in the event of reuse or distribution, the terms of this license are made clear.
